Home › Free Stock Grades › ANNX
Annexon, Inc. (ANNX) Stock Grade
ANNX · Healthcare
C
Market Cap
$657.0M
P/E Ratio
—
Revenue Growth (YoY)
0.0%
Net Margin
0.0%
Return on Equity
—
Dividend Yield
None
About Annexon, Inc.'s fundamentals
Annexon is a biotechnology company with a market capitalization of $657.0 million that reported no revenue growth year-over-year and a net loss in its latest annual statement, resulting in a net margin of 0.0%. The company does not currently pay dividends. As a pre-revenue or early-stage biotech firm, traditional profitability metrics like price-to-earnings ratio and return on equity are not applicable, which is typical for companies in clinical development stages focused on bringing new therapeutic candidates to market.